1. Home
  2. AMH vs NBIX Comparison

AMH vs NBIX Comparison

Compare AMH & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Homes 4 Rent of Beneficial Interest

AMH

American Homes 4 Rent of Beneficial Interest

HOLD

Current Price

$30.83

Market Cap

11.8B

Sector

Real Estate

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$155.43

Market Cap

14.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMH
NBIX
Founded
2012
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8B
14.4B
IPO Year
2013
1996

Fundamental Metrics

Financial Performance
Metric
AMH
NBIX
Price
$30.83
$155.43
Analyst Decision
Buy
Strong Buy
Analyst Count
15
19
Target Price
$38.20
$173.79
AVG Volume (30 Days)
2.5M
969.9K
Earning Date
10-29-2025
10-28-2025
Dividend Yield
3.89%
N/A
EPS Growth
23.05
12.44
EPS
1.18
4.19
Revenue
$1,831,836,000.00
$2,682,700,000.00
Revenue This Year
$8.29
$23.76
Revenue Next Year
$4.11
$18.01
P/E Ratio
$26.14
$37.10
Revenue Growth
7.71
19.61
52 Week Low
$30.63
$84.23
52 Week High
$39.49
$157.67

Technical Indicators

Market Signals
Indicator
AMH
NBIX
Relative Strength Index (RSI) 34.23 64.81
Support Level $31.80 $150.26
Resistance Level $32.73 $154.35
Average True Range (ATR) 0.49 4.16
MACD -0.09 1.07
Stochastic Oscillator 9.31 93.25

Price Performance

Historical Comparison
AMH
NBIX

About AMH American Homes 4 Rent of Beneficial Interest

American Homes 4 Rent is a real estate investment trust focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's geographical markets include Dallas, Texas; Indianapolis, Indiana; Atlanta, Georgia; and Charlotte, North Carolina in terms of the number of properties in each.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Share on Social Networks: